Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 63 Neoplasms 40 Colorectal Neoplasms 30 Uterine Cervical Neoplasms 29 Carcinoma, Hepatocellular 23 Stomach Neoplasms 19 Prostatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Ovarian Neoplasms 16 Lung Neoplasms 14 Esophageal Neoplasms 13 Multiple Myeloma 12 Pancreatic Neoplasms 11 Endometrial Neoplasms 10 Urinary Bladder Neoplasms 9 Motor Activity 9 Colonic Neoplasms 9 Recurrence 8 Rectal Neoplasms 8 Lymphoma, Follicular 8 Melanoma 7 Lymphoma 7 Liver Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Triple Negative Breast Neoplasms 6 Sleep Initiation and Maintenance Disorders 6 Sarcopenia 6 Neuroendocrine Tumors 6 Leukemia 6 Hematologic Neoplasms 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Unresectable Pancreatic Cancer × 1 year × Clear all

NCT06135896 2025-06-18

Dulastin

National Cancer Center, Korea

Phase 2 Recruiting

Gastrointestinal

Unresectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡